Pancreatic Cancer Research

ResearcherNational Taiwan UniversityNo recent work listed

Jhe‐Cyuan Guo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6689-9640; OpenAlex author ID A5001184046. Sources: OpenAlex.

Their work

Papers
6 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 2 papers · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 1 paper

Papers 6

  1. Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patients. First author DOI 10.1016/j.jfma.2019.01.015↗
  2. Postoperative Imaging and Tumor Marker Surveillance in Resected Pancreatic Cancer. First author DOI 10.3390/jcm8081115↗
  3. Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine… Co-author DOI 10.1371/journal.pone.0180628↗
  4. Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancer. First author DOI 10.1111/jgh.13395↗
  5. Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer. Co-author DOI 10.3748/wjg.v22.i32.7275↗
  6. Sequential gemcitabine and platinum versus first-line combination of gemcitabine and platinum for advanced pancreatic cancer treatment: a retrospective study. Co-author DOI 10.1007/s10147-013-0622-x↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shih‐Hung Yang · 6 shared papers, 2014–2020 · strength 0.54
  2. Yu‐Wen Tien · 5 shared papers, 2016–2020 · strength 0.45
  3. Sung‐Hsin Kuo · 5 shared papers, 2016–2020 · strength 0.45
  4. Ann‐Lii Cheng · 4 shared papers, 2016–2020 · strength 0.33
  5. Kun‐Huei Yeh · 3 shared papers, 2016–2020 · strength 0.25
  6. Hsu Wu · 2 shared papers, 2016–2019 · strength 0.18
  7. Ting‐Chun Kuo · 2 shared papers, 2016–2017 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.